Literature DB >> 9752823

Association of mannose-binding-lectin deficiency with severe atherosclerosis.

H O Madsen, V Videm, A Svejgaard, J L Svennevig, P Garred.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9752823     DOI： 10.1016/S0140-6736(05)61513-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  35 in total

1.  Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Vinay K Bhatia; Sheng Yun; Viola Leung; David C Grimsditch; G Martin Benson; Marina B Botto; Joseph J Boyle; Dorian O Haskard
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  Recombinant form of human wild type mannan-binding lectin (MBL/A) but not its structural variant (MBL/C) promotes phagocytosis of zymosan by activating complement.

Authors:  Rema Rajagopalan; Takazvida Nyaundi; Veena P Salvi; Nenoo Rawal
Journal:  Mol Immunol       Date:  2010-06-25       Impact factor: 4.407

3.  Innate immune proteins C1q and mannan-binding lectin enhance clearance of atherogenic lipoproteins by human monocytes and macrophages.

Authors:  Deborah A Fraser; Andrea J Tenner
Journal:  J Immunol       Date:  2010-09-10       Impact factor: 5.422

4.  Mannose-binding lectin-associated serine protease-1 is a significant contributor to coagulation in a murine model of occlusive thrombosis.

Authors:  Laura R La Bonte; Vasile I Pavlov; Ying S Tan; Kazue Takahashi; Minoru Takahashi; Nirmal K Banda; Chenhui Zou; Teizo Fujita; Gregory L Stahl
Journal:  J Immunol       Date:  2011-12-12       Impact factor: 5.422

5.  Effects of mannose-binding lectin polymorphisms on irinotecan-induced febrile neutropenia.

Authors:  Jessica M van der Bol; Floris A de Jong; Ron H van Schaik; Alex Sparreboom; Marianne A van Fessem; Fleur E van de Geijn; Paul L van Daele; Jaap Verweij; Stefan Sleijfer; Ron H Mathijssen
Journal:  Oncologist       Date:  2010-10-07

Review 6.  Mannose-binding lectin and maladies of the bowel and liver.

Authors:  Daniel-L Worthley; Peter-G Bardy; David-L Gordon; Charles-G Mullighan
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

7.  Association between familial deficiency of mannose-binding lectin and mutations in the corresponding gene and promoter region.

Authors:  M M M Salimans; W A Bax; F Stegeman; M van Deuren; A K M Bartelink; H van Dijk
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

8.  Mannose-binding lectin genotype and phenotype in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

Authors:  L G Mellbin; A Hamsten; K Malmberg; R Steffensen; L Rydén; J Ohrvik; T K Hansen
Journal:  Diabetes Care       Date:  2010-08-06       Impact factor: 17.152

9.  Deficiency of complement factor MBL in a patient required cardiac surgery after an acute myocardial infarction with underlining chronic lymphocytic leukemia.

Authors:  Lawrence T Lai; Daniel C Lee; Wilson Ko; Ketan Shevde; Ming Zhang
Journal:  Int J Cardiol       Date:  2008-11-26       Impact factor: 4.164

10.  Fluorochrome-linked immunoassay for functional analysis of the mannose binding lectin complement pathway to the level of C3 cleavage.

Authors:  Mary C Walsh; Lisa A Shaffer; Benjamin J Guikema; Simon C Body; Stanton K Shernan; Amanda A Fox; Charles D Collard; Michael Fung; Ronald P Taylor; Gregory L Stahl
Journal:  J Immunol Methods       Date:  2007-05-11       Impact factor: 2.303
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.